Trimethoprim is a synthetic antibiotic primarily used for the treatment of urinary tract infections. It acts by inhibiting the bacterial enzyme dihydrofolate reductase, thereby blocking the synthesis of tetrahydrofolic acid, a molecule essential for bacterial DNA replication. Though not directly related to catalytic processes, understanding how trimethoprim functions provides valuable insights into enzyme inhibition and drug design.
